Bexen Cardio provides cardioprotection to Madrid by equipping the entire EMT fleet with 2,200 defibrillators
Bexen Cardio, part of the MONDRAGON Corporation and the only national manufacturer of defibrillators, is responsible for supplying, installing, and maintaining the 2,200 Reanibex 100 automated external defibrillators (AEDs) that will equip the EMT Madrid bus fleet.
The project to provide the entire EMT Madrid bus fleet with cardioprotection systems was presented today at Cibeles Palace, in an event chaired by Madrid Mayor José Luis Martínez-Almeida, accompanied by the Delegate for Urban Planning, Environment and Mobility, Borja Carabante, and EMT Madrid CEO Alfonso Sánchez.
During the presentation, Bexen Cardio demonstrated how the Reanibex 100 defibrillator works, as well as its connected cardioprotection solution, which will enable real-time monitoring of the operational status of the devices installed across the fleet.
The event was also attended by Javier Amézaga, Vice President of MONDRAGON Corporation; Ramón Gómez Ugalde, Director of Institutional Relations at MONDRAGON; and Digna González, Managing Director of Bexen Cardio.
The installation of defibrillators began in July, and the project will be completed next October, by which time all municipal buses will have a defibrillator on board. This initiative ensures the safety of millions of passengers and positions Madrid as a benchmark for the implementation of cardioprotection systems in public transport.
With the installation of 2,200 defibrillators across the entire fleet, Madrid will have a unique mobile cardioprotection network. The devices will circulate continuously throughout the city, helping to reduce the time it takes to access a defibrillator in the event of a cardiac arrest, a key factor in increasing the chances of survival.
EMT Madrid buses transport hundreds of thousands of passengers every day, making the addition of defibrillators an important step in turning the municipal network into a cardioprotected space serving the public. The visible presence of these devices also helps raise awareness of the importance of acting quickly in the event of a cardiac arrest and initiating the chain of survival as soon as possible.
The contract, awarded to Bexen Cardio last March, is valued at €2,897,040 (excluding VAT) and includes the supply, installation, maintenance and incident management of the devices over a five-year period, under a leasing model.
Technology to Save Lives
The buses are equipped with the Reanibex 100, a Spanish-made automated external defibrillator (AED) designed and manufactured by Bexen Cardio. The device is suitable for treating both adult and paediatric patients and has been developed to be used easily, safely and intuitively by people without medical training in an emergency situation.
The device guides the rescuer throughout the entire resuscitation process with clear voice instructions, from placing the electrodes to performing CPR and, when appropriate, delivering the shock. It also incorporates CPR assistance features, such as a metronome and a real-time feedback system on chest compression rate, helping to improve CPR quality and increase the chances of survival in the event of cardiac arrest.
The Reanibex 100 also incorporates an integrated geolocation system that makes it possible to track the location of each device at all times. Its design allows for easy integration into public spaces and public transport vehicles, ensuring quick and simple operation when every minute counts.
24/7 Remote Monitoring
Bexen Cardio’s comprehensive connected cardioprotection solution enables the remote monitoring of the 2,200 defibrillators installed across the EMT Madrid bus fleet, 24 hours a day. Continuous monitoring of all devices allows any incidents to be quickly detected and managed, ensuring their availability and proper operational condition at all times.
In an emergency, removing the defibrillator from its holder automatically triggers an alert to the 112 emergency services and sends the device’s location, facilitating coordination with emergency responders. The device switches on automatically when the lid is opened and guides the user through the entire process with clear voice instructions.
Testimonials
Digna González, Managing Director of Bexen Cardio, highlighted that: “At BEXEN CARDIO, we are proud to be part of a project that brings cardioprotection into the daily lives of thousands of people. As the only national manufacturer of defibrillators, we contribute our experience and technical expertise to provide EMT Madrid with a solution that is accessible and tailored to its needs, aimed at helping save lives when every minute counts.”
Javier Amézaga, Vice President of MONDRAGON Corporation, stated: “MONDRAGON develops advanced technology in the service of people, generating a positive impact on society. This new service also strengthens MONDRAGON’s diversified presence in Madrid, where nearly 3,000 people work across the industrial, services, financial and university sectors. We are delighted that a company within our ecosystem, BEXEN CARDIO, is helping to strengthen cardioprotection across the city of Madrid through its public transport network. We congratulate the city of Madrid on this pioneering initiative, which will help save lives.”